Article
S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against Prostate cancer
2022-08-01
Abstract excerpt
<title>Abstract</title> <p>Sustained oxidative overload in castration-resistant prostate cancer (CRPC) cells potentiates the overall tumor microenvironment (TME). Targeting the TME using colony-stimulating factor 1 receptor (CSF1R) inhibition is a promising therapy for CRPC. However, the therapeutic response to sustained CSF1R blockade therapy (CSF1Ri) is limited as a monotherapy. We postulated that one of the ca...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d0830fbe-d42f-5b14-be74-34e7922252b9
- DOI
- 10.21203/rs.3.rs-1833388/v1
